COVID-19 vaccine makers rebound amid post-pandemic prospects
https://seekingalpha.com/news/4109471-covid-19-vaccine-makers-gain-post-pandemic-prospects?source=feed_sector_healthcare
May 22, 2024 - Shares of Moderna (MRNA), Pfizer (PFE), BioNTech (BNTX), and Novavax (NVAX) are rising as investors look for their post-pandemic growth potential. Read more here.
0
How Do Li Auto (LI) & XPeng (XPEV) Stack Up Post Q1 Earnings?
https://www.zacks.com/stock/news/2277334/how-do-li-auto-li-xpeng-xpev-stack-up-post-q1-earnings?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-2277334
May 22, 2024 - While Li Auto's (LI) net income falls 37% year over year to roughly $82 million in the first quarter, XPeng's (XPEV) bottom line improves as loss narrows 41.4% year over year.
0
A Far-Right Indian News Site Posts Racist Conspiracies. US Tech Companies Keep Platforming It
https://www.wired.com/story/india-opindia-google-facebook-advertising/
May 22, 2024 - OpIndia claims “Islamophobia does not exist.” A new report shared exclusively with WIRED finds Google’s programmatic ads are running next to its content.
0
NICE Ltd. Stock's Risk-Reward Appears To Be Better Post Q1 Results
https://seekingalpha.com/article/4694673-nice-stock-risk-reward-appears-better-post-q1-results?source=feed_tag_israel
May 20, 2024 - NICE Ltd. experienced a 15% contraction in share price despite delivering healthy Q1 results. Find out why NICE stock is a Buy.
0
American Woodmark (AMWD) to Post Q4 Earnings: What to Expect
https://www.zacks.com/stock/news/2276286/american-woodmark-amwd-to-post-q4-earnings-what-to-expect?cid=CS-ZC-FT-analyst_blog|earnings_preview-2276286
May 20, 2024 - American Woodmark's (AMWD) fiscal fourth-quarter results are likely to witness lower demand and higher operational costs.
0
Photronics (PLAB) to Post Q2 Earnings: What's in the Offing?
https://www.zacks.com/stock/news/2276203/photronics-plab-to-post-q2-earnings-what-s-in-the-offing?cid=CS-ZC-FT-analyst_blog|earnings_preview-2276203
May 20, 2024 - Photronics' (PLAB) second-quarter fiscal 2024 performance is likely to reflect strength in Integrated Circuit (IC) and Flat Panel Display (FPD) segments.
0
Deckers (DECK) to Post Q4 Earnings: What's in the Cards?
https://www.zacks.com/stock/news/2276112/deckers-deck-to-post-q4-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2276112
May 20, 2024 - Deckers' (DECK) fourth-quarter fiscal 2024 results are likely to reflect strength in the HOKA ONE ONE brand.
0
AZUL Posts Wider-Than-Expected Q1 Loss, Sees Y/Y Revenue Rise
https://www.zacks.com/stock/news/2275076/azul-posts-wider-than-expected-q1-loss-sees-y-y-revenue-rise?cid=CS-ZC-FT-analyst_blog|earnings_article-2275076
May 16, 2024 - Azul's first-quarter 2024 revenues benefit from buoyant travel demand.
0
Williams-Sonoma (WSM) to Post Q1 Earnings: What's in Store?
https://www.zacks.com/stock/news/2275056/williams-sonoma-wsm-to-post-q1-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2275056
May 16, 2024 - Williams-Sonoma's (WSM) fiscal Q1 performance is likely to have witnessed rising e-commerce growth, higher merchandise margins and lower costs from supply-chain efficiencies. Yet, weak demand is a risk.
0
Roche (RHHBY) Posts Encouraging Phase I Obesity Drug Data
https://www.zacks.com/stock/news/2274860/roche-rhhby-posts-encouraging-phase-i-obesity-drug-data?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2274860
May 16, 2024 - Data from the study shows that nearly half of the patients who received Roche's (RHHBY) subcutaneously-administered obesity drug lost more than 20% of their body weight after 24 weeks.
0